1 day Ago By Defense World Staff
Research analysts at StockNews.com initiated coverage on shares of T2 Biosystems ( NASDAQ:TTOO – Get Free Report ) in a research note issued to investors on Sunday. The firm set a “sell” rating on the medical equipment provider’s stock.
T2 Biosystems Stock Performance NASDAQ TTOO opened at $0.41 on Friday. T2 Biosystems has a 1 year low of $0.
31 and a 1 year high of $6.95. The company has a fifty day moving average of $0.
53 and a two-hundred day moving average of $2.48. Hedge Funds Weigh In On T2 Biosystems A hedge fund recently bought a new stake in T2 Biosystems stock.
Armistice Capital LLC acquired a new position in shares of T2 Biosystems, Inc. ( NASDAQ:TTOO – Free Report ) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,658,000 shares of the medical equipment provider’s stock, valued at approximately $8,854,000.
Armistice Capital LLC owned approximately 9.49% of T2 Biosystems at the end of the most recent reporting period. Institutional investors own 23.
18% of the company’s stock. About T2 Biosystems T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Read More Five stocks we like better than T2 Biosystems With Risk Tolerance, One Size Does Not Fit All Quantum Opportunity: Skywater Technology’s Long-Term Potential 5 Top Rated Dividend Stocks to Consider Nebius Group: The Rising Star in AI Infrastructure Profitably Trade Stocks at 52-Week Highs MarketBeat Week in Review – 12/30 – 1/03 Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter ..
